SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-054254
Filing Date
2020-10-07
Accepted
2020-10-07 21:25:33
Documents
2
Period of Report
2020-10-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1525
2 POA DOCUMENT poa.txt EX-24.3_940901 4064
  Complete submission text file 0001209191-20-054254.txt   7261
Mailing Address C/O WEBMD HEALTH CORP. 111 EIGHTH AVENUE NEW YORK NY 10011
Business Address
Vuori Kristiina MD (Reporting) CIK: 0001612627 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37418 | Film No.: 201230003

Mailing Address 11 TIMES SQUARE 33RD FLOOR NEW YORK NY 10036
Business Address 11-12 ST. JAMES'S SQUARE SUITE 1, 3RD FLOOR LONDON X0 SW1Y 4LB 44 203 318 9708
Axovant Gene Therapies Ltd. (Issuer) CIK: 0001636050 (see all company filings)

IRS No.: 981333697 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations